Facing the tsunami of the epidemic, China still rejects Western vaccines provided by Europe and the United States, and South Korean vaccine manufacturers are not willing to provide Chinese vaccines.

(Bloomberg)

[Financial Channel/Comprehensive Report] Facing the tsunami of the epidemic, China still refuses Western vaccines provided by Europe and the United States. The CEO of SK Bioscience, a South Korean biotechnology company that helps AstraZeneca (AZ) and Novavax produce new crown vaccines, said that in view of Beijing’s National pride and insistence on using domestically produced vaccines, even if China is suffering from a major outbreak, it is unlikely to provide a Covid vaccine to China, which is very unrealistic.

Jaeyong Ahn, CEO of SK Bioscience, said in an interview with the Financial Times that China is now at the epicenter of the pandemic, and unless there are "dramatic" negotiations, it will not be easy for us to supply vaccines there because of (Chinese) national pride And reasons such as maintaining domestic vaccines.

Please read on...

Jae-yong Ahn bluntly said that although China is suffering from a major outbreak, the plan to provide Chinese vaccines is very unrealistic, and SK will only continue to monitor whether other mutant strains appear in China.

Since SK Bioscience helped AstraZeneca (AZ) and Novavax produce the new crown vaccine, its revenue surged fivefold between 2019 and 2021, reaching 929 billion won.

Last year, SK also developed its own Covid vaccine, which was approved for use in South Korea in June of the same year. It is currently waiting for approval by the World Health Organization and the European Union, and is expected to be approved in the first half of this year.

Grasp the pulse of the economy with one hand I subscribe to Free Finance Youtube channel

Already added friends, thank you

Welcome to 【Free Finance】

feel good

Already liked it, thank you.

related news